Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Impact of disease severity and comorbidities on length of stay (LOS) in COPD

James Rushton, Ian Evans, Samantha Carr, Claire Mathews, Wendy Morgan, Steven Dean, Carlton Chisambara, Naveed Mustfa, Helen Stone, Imran Hussain
European Respiratory Journal 2016 48: PA4157; DOI: 10.1183/13993003.congress-2016.PA4157
James Rushton
1Respiratory Medicine, University Hospitals of North Midlands NHS Trust, Stoke on Trent, StaffordshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Evans
1Respiratory Medicine, University Hospitals of North Midlands NHS Trust, Stoke on Trent, StaffordshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Carr
1Respiratory Medicine, University Hospitals of North Midlands NHS Trust, Stoke on Trent, StaffordshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Mathews
1Respiratory Medicine, University Hospitals of North Midlands NHS Trust, Stoke on Trent, StaffordshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy Morgan
1Respiratory Medicine, University Hospitals of North Midlands NHS Trust, Stoke on Trent, StaffordshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Dean
1Respiratory Medicine, University Hospitals of North Midlands NHS Trust, Stoke on Trent, StaffordshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlton Chisambara
1Respiratory Medicine, University Hospitals of North Midlands NHS Trust, Stoke on Trent, StaffordshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naveed Mustfa
1Respiratory Medicine, University Hospitals of North Midlands NHS Trust, Stoke on Trent, StaffordshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Stone
1Respiratory Medicine, University Hospitals of North Midlands NHS Trust, Stoke on Trent, StaffordshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Imran Hussain
1Respiratory Medicine, University Hospitals of North Midlands NHS Trust, Stoke on Trent, StaffordshireUnited Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

Introduction: COPD is a chronic disease with well described comorbidities and a leading cause of non-elective hospital admission in the UK. We aimed to determine the effects of comorbidity and disease severity, according to GOLD criteria, on the LOS and readmission rates in patients admitted with exacerbations of COPD.

Methods: Data was prospectively collected on 119 patients admitted to a large teaching hospital between November and December 2015.

Results: The mean patient age was 70.5 years and the mean FEV1 was 48% predicted (severe/stage III). 40 patients (33%) were readmitted in the 30 days following discharge, and of these 18 had more than 1 readmission. 95 patients (80%) had more than 1 comorbidity (mean 2.6 per patient, range 1-8), and 11 (8%) patients died following their admission. The mean LOS was 5.5 days (range 0 – 24) and the number of comorbidities did not correlate with LOS, but severe disease was associated with an increased LOS.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Conclusion: Increasing severity of COPD was associated with an increased LOS, and there was no significant relationship between the number of comorbidities and LOS or readmissions.

  • COPD - exacerbations
  • Comorbidities
  • Interaction
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of disease severity and comorbidities on length of stay (LOS) in COPD
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Impact of disease severity and comorbidities on length of stay (LOS) in COPD
James Rushton, Ian Evans, Samantha Carr, Claire Mathews, Wendy Morgan, Steven Dean, Carlton Chisambara, Naveed Mustfa, Helen Stone, Imran Hussain
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4157; DOI: 10.1183/13993003.congress-2016.PA4157

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Impact of disease severity and comorbidities on length of stay (LOS) in COPD
James Rushton, Ian Evans, Samantha Carr, Claire Mathews, Wendy Morgan, Steven Dean, Carlton Chisambara, Naveed Mustfa, Helen Stone, Imran Hussain
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4157; DOI: 10.1183/13993003.congress-2016.PA4157
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients
  • Prevalence of refractory asthma in population with severe asthma
  • Use of clinical characteristics to predict spirometric classification of obstructive lung disease
Show more 5.2 Monitoring Airway Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society